Association between the TRAIL single nucleotide polymorphism rs1131580 and type 2 diabetes mellitus in a Han Chinese population

Genetics and Molecular Research

Volumn 12, Issue 3, 2013, Pages 3455-3464

  Yu, M Y ^a,b   Zhao, P Q ^a,c   Yan, X H ^d   Liu, B ^a   Zhang, Q Q ^a   Wang, R ^a   Ma, C H ^a   Liang, X H ^a   Zhu, F L ^a   Gao, L F ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Binzhou Vocation College   (China)

^c ZIBO CENTRAL HOSPITAL   (China)

^d Shandong Medical College   (China)

Author keywords

Polymerase chain reaction restriction fragment length polymorphism; Single nucleotide polymorphism; Tumor necrosis factor related apoptosis inducing ligand; Type 2 Diabetes mellitus

Indexed keywords

CREATININE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ALLELE; ARTICLE; CHINA; CHINESE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84884580043     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.September.10.2     Document Type: Article

References (38)

1. Arase Y, Suzuki F, Ikeda K, Kumada H, et al. (2009). Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. J. Gastroenterol. 44: 1064-1070.
2. Boraska V, Rayner NW, Groves CJ, Frayling TM, et al. (2010). Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med. Genet. 11: 69.
3. Chang YH, Lin KD, He SR, Hsieh MC, et al. (2011). Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. Metabolism 60: 1064-1069.
4. Chui MH, Papanikolaou Y, Fontaine-Bisson B, Turcotte J, et al. (2007). The TNF-alpha-238G > a single-nucleotide polymorphism protects against memory decline in older adults with type 2 diabetes. Behav. Neurosci. 121: 619-624.
5. Corallini F, Celeghini C, Rizzardi C, Pandolfi A, et al. (2007). Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro. J. Cell Physiol. 212: 89-95.
6. Fan JG, Li F, Cai XB, Peng YD, et al. (2007). Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. J. Gastroenterol. Hepatol. 22: 1086-1091.
7. Freeman H and Cox RD (2006). Type-2 diabetes: a cocktail of genetic discovery. Hum. Mol. Genet. 15 Spec No 2: R202-R209.
8. Gray HL, Sorensen EL, Hunt JS and Ober C (2001). Three polymorphisms in the 3' UTR of the TRAIL (TNF-related apoptosis-inducing ligand) gene. Genes Immun. 2: 469-470.
9. Hanley S, Liu S, Lipsett M, Castellarin M, et al. (2006). Tumor necrosis factor-alpha production by human islets leads to postisolation cell death. Transplantation 82: 813-818.
10. Jung JH, Chae YS, Moon JH, Kang BW, et al. (2010). TNF superfamily gene polymorphism as prognostic factor in early breast cancer. J. Cancer Res. Clin. Oncol. 136: 685-694.
11. Kavurma MM, Schoppet M, Bobryshev YV, Khachigian LM, et al. (2008). TRAIL stimulates proliferation of vascular smooth muscle cells via activation of NF-kappaB and induction of insulin-like growth factor-1 receptor. J. Biol. Chem. 283: 7754-7762.
12. Kawano N, Mori K, Emoto M, Lee E, et al. (2011). Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 91: 316-320.
13. Kikuchi S, Miyagishi R, Fukazawa T, Yabe I, et al. (2005). TNF-related apoptosis inducing ligand (TRAIL) gene polymorphism in Japanese patients with multiple sclerosis. J. Neuroimmunol. 167: 170-174.
14. Kumar D, Robertson S and Burns KD (2004). Evidence of apoptosis in human diabetic kidney. Mol. Cell Biochem. 259: 67-70.
15. Lamhamedi-Cherradi SE, Zheng S, Tisch RM and Chen YH (2003). Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. Diabetes 52: 2274-2278.
16. Langberg KA, Ma L, Sharma NK, Hanis CL, et al. (2012). Single nucleotide polymorphisms in JAZF1 and BCL11A gene are nominally associated with type 2 diabetes in African-American families from the GENNID study. J. Hum. Genet. 57: 57-61.
17. Lin HM, Lee JH, Yadav H, Kamaraju AK, et al. (2009). Transforming growth factor-beta/Smad3 signaling regulates insulin gene transcription and pancreatic islet beta-cell function. J. Biol. Chem. 284: 12246-12257.
18. Ortiz A, Ziyadeh FN and Neilson EG (1997). Expression of apoptosis-regulatory genes in renal proximal tubular epithelial cells exposed to high ambient glucose and in diabetic kidneys. J. Investig. Med. 45: 50-56.
19. Pal R, Gochhait S, Chattopadhyay S, Gupta P, et al. (2011). Functional implication of TRAIL-716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor. Breast Cancer Res. Treat. 126: 333-343.
20. Rung J, Cauchi S, Albrechtsen A, Shen L, et al. (2009). Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat. Genet. 41: 1110-1115.
21. Sladek R, Rocheleau G, Rung J, Dina C, et al. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445: 881-885.
22. Susa S, Daimon M, Sakabe J, Sato H, et al. (2008). A functional polymorphism of the TNF-alpha gene that is associated with type 2 DM. Biochem. Biophys. Res. Commun. 369: 943-947.
23. Unoki H, Takahashi A, Kawaguchi T, Hara K, et al. (2008). SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 40: 1098-1102.
24. Unoki M, Furuta S, Onouchi Y, Watanabe O, et al. (2000). Association studies of 33 single nucleotide polymorphisms (SNPs) in 29 candidate genes for bronchial asthma: positive association a T924C polymorphism in the thromboxane A2 receptor gene. Hum. Genet. 106: 440-446.
25. Vaccarezza M, Delbello G and Zauli G (2007). A role of the TRAIL-TRAIL receptor system in the pathogenesis of diabetes. Acta Biomed. 78 (Suppl 1): 262-267.
26. Villegas R, Shu XO, Li H, Yang G, et al. (2006). Physical activity and the incidence of type 2 diabetes in the Shanghai women's health study. Int. J. Epidemiol. 35: 1553-1562.
27. Voruganti VS, Cole SA, Ebbesson SO, Goring HH, et al. (2010). Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos. Am. J. Clin. Nutr. 91: 1574-1583.
28. Wachlin G, Augstein P, Schroder D, Kuttler B, et al. (2003). IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction. J. Autoimmun. 20: 303-312.
29. Wang Q, Ji Y, Wang X and Evers BM (2000). Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene. Biochem. Biophys. Res. Commun. 276: 466-471.
30. Wanner C and Krane V (2011). Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitus. Kidney Blood Press Res. 34: 209-217.
31. Watanabe S, Takeshige K and Muta T (2007). A cis-element in the 3'-untranslated region of IkappaB-zeta mRNA governs its stimulus-specific expression. Biochem. Biophys. Res. Commun. 356: 785-791.
32. Wiley SR, Schooley K, Smolak PJ, Din WS, et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3: 673-682.
33. Yan X, Xu L, Qi J, Liang X, et al. (2009). sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics 61: 551-556.
34. Yang HL, Kong L, Hou LL, Shen HF, et al. (2012). Analysis of risk factors for polypoid lesions of gallbladder among health examinees. World J. Gastroenterol. 18: 3015-3019.
35. Zauli G, Toffoli B, di Iasio MG, Celeghini C, et al. (2010). Treatment with recombinant tumor necrosis factor-related apoptosis-inducing ligand alleviates the severity of streptozotocin-induced diabetes. Diabetes 59: 1261-1265.
36. Zeggini E, Groves CJ, Parkinson JR, Halford S, et al. (2005). Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes. Diabetologia 48: 2013-2017.
37. Zhang XY, Zhang XD, Borrow JM, Nguyen T, et al. (2004). Translational control of tumor necrosis factor-related apoptosis-inducing ligand death receptor expression in melanoma cells. J. Biol. Chem. 279: 10606-10614.
38. Zimmet P, Alberti KG and Shaw J (2001). Global and societal implications of the diabetes epidemic. Nature 414: 782-787.